Drupal.behaviors.print = function(context) {window.print();window.close();}>
Agilent Buying Cancer Diagnostics Company Dako for $2.2B
May 17, 2012
Agilent Buying Cancer Diagnostics Company Dako for $2.2B
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Dako, Pfizer Reach Companion Dx Deal
February 12, 2013 / GenomeWeb Daily News
Agilent Discloses Dako Earnings
September 6, 2012 / GenomeWeb Daily News
Dako Signs Another CDx Deal with Amgen
February 21, 2012 / GenomeWeb Daily News
Dako, Bristol-Myers Ink Pharmacogenomics Deal
November 9, 2011 / GenomeWeb Daily News
Leica, Synthon Biopharmaceuticals Partner on CDx Development
March 12, 2013 / GenomeWeb Daily News